Search

everythinglearnresearchcommunity

for

Search:↓

YH0618 helps reduce chemotherapy-induced hair loss by targeting specific proteins and pathways.

NDRG1 protein helps infantile hemangioma, a common infant tumor, to grow, and its mismanagement by FOXO1 protein plays a big role in causing the tumor.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

Tofacitinib helped a woman regrow hair with no major side effects.

Sorafenib can cause rare skin reactions, but treatment can continue with additional care.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

Blocking casein kinase 1 in skin cells can help melanocyte precursors move better, potentially helping with conditions like vitiligo or gray hair.

ETS2 is crucial in squamous cell carcinoma development and could be a therapeutic target.

Ruxolitinib can help regrow hair in severe alopecia areata.

Topical tofacitinib shows promise as a future treatment for alopecia areata.

Androgen receptors help prostate cancer cells grow and resist drugs.

Ingenol mebutate gel changes gene expression related to skin development and immune response in actinic keratosis.

Tofacitinib effectively improved severe skin symptoms in a patient with Hypohidrotic Ectodermal Dysplasia.

The study found that analyzing certain cell signaling pathways is not a reliable method to tell apart two types of skin tumors.

Alpha-difluoromethylornithine prevents cancer in mice but causes hair loss.

Cepharanthine can potentially treat gastric cancer by stopping tumor growth.

VEGF165 influences hair follicle cell growth and movement through VEGFR-2 activation.

CDK inhibitors may help treat ARDS and psoriasis but need more testing for safety and effectiveness.

Overexpressing GLI-1 in mice skin can cause tumors like human basal cell carcinomas.

Key genes and pathways involved in thyroid eye disease were identified, aiding potential treatment and diagnosis.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

ROR-alpha may increase the growth of certain breast cancer cells by boosting aromatase, which could affect breast cancer prognosis.

The combination of Typhonium flagelliforme extract and natural interferons effectively reduces tumor growth in mice.

Long-term use of 5α-reductase inhibitors may improve survival in men with kidney cancer.

Upadacitinib can cause hypersensitivity that worsens ulcerative colitis symptoms.

Combining delgocitinib ointment with excimer laser can effectively treat severe alopecia areata.

Protein kinase C epsilon may increase skin cancer risk by affecting nearby cells.